Clinical Trial Update: Sirolimus for Cowden Syndrome With Colon Polyposis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of sirolimus for Cowden syndrome with colon polyposis has completed, sponsored by Ohio State University. The study targets PTEN hamartoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bannayan-riley-ruvalcaba Syndrome
• Colorectal Polyposis
• Cowden Syndrome
• Pten Hamartoma Tumor Syndrome

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Ohio State University | Conditions: PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome | Phase 2 | Status: COMPLETED